This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Merz Pharma Gmbh & Co. Kgaa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Susanna Roll - Innovator in Botulinum Toxin Treatments
Introduction
Susanna Roll is an accomplished inventor based in Stadecken-Elsheim, Germany. She is currently associated with Merz Pharma GmbH & Co. KGaA, where she contributes her expertise in the field of medical treatments. Although she has not yet been granted any patents, her work focuses on innovative applications of botulinum toxin for various medical conditions.
Latest Patent Applications
Susanna Roll has been involved in several notable patent applications. One of her latest applications is titled "High Dose and Low Volume Botulinum Toxin Treatment of Facial Wrinkles." This invention relates to the use of botulinum toxin for the treatment of facial wrinkles, wherein botulinum toxin is administered at high doses (e.g., 50 U to 200 U) using small injection volumes (e.g., 0.05 ml to 0.35 ml). Furthermore, the present invention outlines a method for treating facial wrinkles, such as glabellar frown lines, by injecting small volumes of a highly concentrated botulinum toxin solution into a target facial area of a subject. Another significant application is "Use of Recombinant Clostridial Neurotoxins for the Treatment of Patients Having Certain Muscle-Related Disorders." This invention explores novel uses of recombinant clostridial neurotoxins that exhibit decreased duration of effect, particularly for treating patients who have experienced muscle-related disorders and/or injuries.
Conclusion
Susanna Roll is a dedicated inventor making strides in the field of botulinum toxin treatments. Her innovative approaches have the potential to significantly impact medical practices related to facial aesthetics and muscle-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile